News
The science of senolytics: breakthroughs in the future of ageing
Is there a cure for ageing? So far, the quest for immortality has been an unsuccessful one with no evidence or promising discoveries. Until now...
Ranelagh researcher wows with project related to Irish ageing
Sandford Park student Oscar Despard scooped the top individual gong at the BT Young Scientist Exhibition for his project, entitled Applying Data-Driven Experimental Analysis to the…
Can we stop ageing?
We’re pretty obsessed with the concept of ageing. Ancient civilizations supposedly sought an ‘elixir of life’, and today many of us get hung up on finding a way to ‘younger looking…
Northumbria University academics seek over 65s for Healthy Ageing research
Researchers from Northumbria University are asking adults aged 65 or over to spare some time to help with their latest research into reducing loneliness in older people and improving…
We won't find a cure for ageing until we can properly measure it
Ageing is malleable. We think this may be true today, but for most of human history it seemed completely implausible. Ageing has always been one of the fixed constants of life. So…
Should we treat ageing like a disease?
We all age as time goes by. The idea that ageing is a natural and inevitable process is ancient. So much so, that when a nonagenarian dies, we say it’s “of old age” or “natural causes…
Children born now face longer period of ill health in old age
ONS study finds growth in healthy life expectancy has not kept up with greater longevity. Children born today are likely to spend a larger proportion of their lives in poor health…
Addressing New Challenges Posed by an Ageing Society
SMU President Prof Lily Kong shares with university leaders SMU’s education and research strategies to meet the needs of an ageing population...
Scientists develop a ‘clock’ that can measure biological age based on blood proteins
A few hundred of the thousands of proteins circulating in our blood turn out to be a fairly accurate forecaster of a person’s age, scientists reported Thursday — though one’s…
Biogen’s stock rises 3% after company releases new data on late-stage Alzheimer’s drug
Biogen shares rose Thursday after the biotech firm offered more data on its late-stage Alzheimer’s drug, aducanumab.